BG63086B1 - Метод за изолиране на клавуланова киселина от ферментационна хранителна среда чрез ултрафилтруване - Google Patents

Метод за изолиране на клавуланова киселина от ферментационна хранителна среда чрез ултрафилтруване Download PDF

Info

Publication number
BG63086B1
BG63086B1 BG102253A BG10225398A BG63086B1 BG 63086 B1 BG63086 B1 BG 63086B1 BG 102253 A BG102253 A BG 102253A BG 10225398 A BG10225398 A BG 10225398A BG 63086 B1 BG63086 B1 BG 63086B1
Authority
BG
Bulgaria
Prior art keywords
clavulanic acid
filtrate
ultrafiltration
isolation
pharmaceutically acceptable
Prior art date
Application number
BG102253A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102253A (en
Inventor
Egidij Capuder
Original Assignee
Lek Pharmaceutical And Chemical Co. D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceutical And Chemical Co. D.D. filed Critical Lek Pharmaceutical And Chemical Co. D.D.
Publication of BG102253A publication Critical patent/BG102253A/xx
Publication of BG63086B1 publication Critical patent/BG63086B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/10—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D503/12—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6
    • C07D503/14—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, attached in position 3
    • C07D503/16—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical
    • C07D503/18—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
BG102253A 1995-08-28 1998-02-16 Метод за изолиране на клавуланова киселина от ферментационна хранителна среда чрез ултрафилтруване BG63086B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9500265A SI9500265A1 (en) 1995-08-28 1995-08-28 Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
PCT/GB1996/002083 WO1997008175A1 (en) 1995-08-28 1996-08-27 Isolation of clavulanic acid from fermentation broth by ultrafiltration

Publications (2)

Publication Number Publication Date
BG102253A BG102253A (en) 1998-08-31
BG63086B1 true BG63086B1 (bg) 2001-03-30

Family

ID=20431679

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102253A BG63086B1 (bg) 1995-08-28 1998-02-16 Метод за изолиране на клавуланова киселина от ферментационна хранителна среда чрез ултрафилтруване

Country Status (20)

Country Link
US (2) US6127358A (ru)
EP (1) EP0859780A1 (ru)
JP (1) JP2000512125A (ru)
KR (1) KR19990035966A (ru)
CN (1) CN1101396C (ru)
AU (1) AU714892B2 (ru)
BG (1) BG63086B1 (ru)
CA (1) CA2226683C (ru)
CZ (1) CZ31898A3 (ru)
EE (1) EE03567B1 (ru)
HU (1) HU221353B1 (ru)
NZ (1) NZ316136A (ru)
PL (1) PL324855A1 (ru)
RO (1) RO116813B1 (ru)
RU (1) RU2169151C2 (ru)
SI (1) SI9500265A1 (ru)
SK (1) SK10398A3 (ru)
UA (1) UA59343C2 (ru)
WO (1) WO1997008175A1 (ru)
ZA (1) ZA967273B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400033B (de) 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ES2105988B1 (es) * 1996-03-15 1998-07-01 Antibioticos Sa Procedimiento para purificar 7-sustituido-amino-desacetoxi-cefalosporinas mediante el empleo de membranas de filtracion.
GB0022841D0 (en) 2000-09-18 2000-11-01 Smithkline Beecham Plc Process
JP2004094465A (ja) * 2002-08-30 2004-03-25 Fujitsu Ltd 解析支援装置
CN102933717A (zh) * 2007-04-27 2013-02-13 科学与工业研究委员会 在固态发酵中采用棒状链霉菌mtcc 1142制备棒酸的方法
CN102838624B (zh) * 2012-09-07 2014-10-29 安徽普朗膜技术有限公司 一种从发酵液中纯化克拉维酸的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873425A (en) * 1971-11-19 1975-03-25 Tatsuyoshi Kobayashi Process for producing itaconic acid
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
IE41110B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Esters of clavulanic acid
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
US4148880A (en) * 1975-08-13 1979-04-10 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
GB1563103A (en) * 1975-10-13 1980-03-19 Beecham Group Ltd Process for the preparation of clavulanic acid
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
JPS5791196A (en) * 1980-11-27 1982-06-07 Takeda Chem Ind Ltd Separation of inosine, guanosine or their mixture from cell bodies and high polymeric substances
JPS6070092A (ja) * 1983-09-26 1985-04-20 Ajinomoto Co Inc グルタミン酸発酵液からのグルタミン酸結晶の取得法
AU600655B2 (en) * 1984-10-27 1990-08-23 Beecham Group Plc Preparation of clavulanic acid and its salts and esters
IT1221982B (it) * 1987-07-08 1990-08-31 Mini Ricerca Scient Tecnolog Antibiotici ab 006 e processo per la loro produzione
DE3730868A1 (de) * 1987-09-15 1989-03-23 Henkel Kgaa Verfahren zur abtrennung von biotechnisch hergestellten wertstoffen aus einer fermenterbruehe durch querstrom-mikro- und/oder ultrafiltration
ES2010144A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un procedimiento de floculacion-coagulacion de caldos de fermentacion de streptomyces sp. que permite la obtencion directa de liquidos completamente transparentes.
US5024937A (en) * 1989-04-06 1991-06-18 Dow Corning Corporation Method for processing aqueous fermentation broths
DE69013471T2 (de) * 1989-12-05 1995-03-30 Merck & Co Inc Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
JPH0475595A (ja) * 1990-07-17 1992-03-10 Kanebo Ltd フェニル配糖体の製造法
US5268283A (en) * 1990-10-05 1993-12-07 Miles Inc. Method for the production of detergent builder formulations utilizing spray granulated citric acid and salts thereof
DE4031854A1 (de) * 1990-10-08 1992-04-09 Basf Ag Mikroorganismus und verfahren zur gewinnung von anthranilsaeure
JP2615272B2 (ja) 1991-03-22 1997-05-28 日本碍子株式会社 蛋白質溶液中の蛋白有価物の回収方法
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
PL306371A1 (en) * 1993-03-26 1995-03-20 Gist Brocades Nv Diamine salts of clavulanic acid
WO1995011295A1 (en) * 1993-10-22 1995-04-27 Gist-Brocades N.V. An improved process to recover an aqueous fermentation broth
AT400846B (de) * 1994-02-25 1996-03-25 Fermic S A De C V Verfahren zur gewinnung und reinigung von alkalimetallsalzen der clavulansäure
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
JP3617091B2 (ja) * 1994-11-30 2005-02-02 味の素株式会社 塩基性アミノ酸の精製方法
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) * 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
ES2101658B1 (es) * 1995-11-23 1998-03-01 Antibioticos Sa Nuevo procedimiento de produccion de acido clavulanico y sus sales.

Also Published As

Publication number Publication date
CZ31898A3 (cs) 1998-07-15
US6274575B1 (en) 2001-08-14
UA59343C2 (ru) 2003-09-15
RU2169151C2 (ru) 2001-06-20
HUP9802532A2 (hu) 1999-03-29
BG102253A (en) 1998-08-31
CN1101396C (zh) 2003-02-12
EP0859780A1 (en) 1998-08-26
HU221353B1 (en) 2002-09-28
AU6829796A (en) 1997-03-19
CA2226683C (en) 2002-04-30
NZ316136A (en) 1998-09-24
HUP9802532A3 (en) 1999-04-28
WO1997008175A1 (en) 1997-03-06
SK10398A3 (en) 1998-07-08
RO116813B1 (ro) 2001-06-29
ZA967273B (en) 1997-03-04
SI9500265A1 (en) 1997-02-28
CN1193975A (zh) 1998-09-23
EE03567B1 (et) 2001-12-17
PL324855A1 (en) 1998-06-22
EE9800060A (et) 1998-08-17
JP2000512125A (ja) 2000-09-19
AU714892B2 (en) 2000-01-13
KR19990035966A (ko) 1999-05-25
CA2226683A1 (en) 1997-03-06
US6127358A (en) 2000-10-03

Similar Documents

Publication Publication Date Title
RU2206613C2 (ru) Способ выделения клавулановой кислоты
US5994534A (en) Process for the preparation of pharmaceutically acceptable salts of clavulanic acid
BG63086B1 (bg) Метод за изолиране на клавуланова киселина от ферментационна хранителна среда чрез ултрафилтруване
JPH11503744A (ja) クラブラン酸塩の製造方法
EP0941229B1 (en) Purification of fermented clavulanic acid
US20010029038A1 (en) Purification of fermented clavulanic acid
CN115385970A (zh) 一种吉他霉素的提取方法